HTGM | HTG Molecular Diagnostics Inc. Profile | MarketWatch Apr 30, 2020 HTGM -- Is Its Stock Price A Worthy Investment? Learn More. HTGM Stock Summary. With a market capitalization of $43,549,435, Htg Molecular Diagnostics Inc has a greater market value than just 13.61% of US stocks. Revenue growth over the past 12 months for Htg Molecular Diagnostics Inc comes in at -11.3%, a number that … HTG Molecular Diagnostics, Inc. (HTGM) Reports Q3 Loss ...
24 Jan 2020 HTG Molecular Diagnostics (NASDAQ:HTGM) was downgraded by Zacks Investment Research from a hold rating to a sell rating in a research Htg Molecular Dia stocks price quote with latest real-time prices, charts, financials , latest news, Zacks Equity Research - ZACKS - Thu May 14, 9:14AM CDT. Prev Close 0.71, 52 Wk Low 0.27. Open 0.78, 52 Wk High 2.28. Day Low 0.65, Volume 6.8M. Day High 0.78, Avg 10D Vol 6.7M 4 days ago Our vendor, Zacks Investment Research, might revise. HTGM | Complete HTG Molecular Diagnostics Inc. stock news by MarketWatch.
Volume (24h): 2.82M: Day Range: 0.4320 - 0.4679 Market Cap: 28.61M: 52W Range:
Volume (24h): 2.82M: Day Range: 0.4320 - 0.4679 Market Cap: 28.61M: 52W Range:
HTGM HTG Molecular Diagnostics, Inc. Common Stock. Data is currently not available. $0.5299. 0.0476 (8.24%) DATA AS OF May 29, 2020. Our vendor, Zacks Investment Research, hasn't provided us HTG Molecular Diagnostics Inc (HTGM) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.19 per share a year ago. These figures Get the latest HTG Molecular Diagnostics, Inc. (HTGM) stock news and headlines to help you in your trading and investing decisions. Zacks. Top Ranked Momentum Stocks to Buy for May 14th HTGM: Get the latest HTG Molecular Diagnostics stock price and detailed information including HTGM news, historical charts and realtime prices. HTG Molecular Diagnostics, Inc. (HTGM) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.17 per share a year ago. The market expects HTG Molecular Diagnostics, Inc. (HTGM) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely In this article you are going to find out whether hedge funds think HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) is a good investment right now. We like to check what the smart money thinks first